The abstract is read at the publisher; the summary is JClub's.
A single-cell RNA-seq atlas of CTCL from 116 patients (over 2 million skin and blood cells) reveals recurrent malignant T-cell transcriptional programs linked to GATA binding protein 3, especially in large cell transformation and advanced-stage disease.
- Why it matters: Advanced-stage CTCL has suboptimal outcomes with few complete, durable responses, and the field lacks a detailed map of oncogenic programs and tumor microenvironment interactions that could expose actionable vulnerabilities.
- What they did: The study compiled the largest available CTCL single-cell RNA-sequencing atlas, then identified recurrent malignant T-cell programs and assessed associations with GATA binding protein 3-dependent programs across disease settings.
- The result: Many programs and microenvironment components are therapeutically targetable with clinically available agents, and the TME’s exhausted effector and cytotoxic T cells suggest immune-checkpoint combinations, including programmed cell death protein 1, as a rational strategy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.